Medical grade silicone market seen reaching $3.74 billion by 2030

The Business Research Company says the medical grade silicone market will grow from $2.77 billion in 2026 to $3.74 billion by 2030, driven by rising medical device production, biocompatible material demand and broader use in implants and wound care. North America led the market in 2025, while the report highlights faster adoption of liquid silicone rubber and high-purity materials.

Why it matters: - Medical grade silicone is a core material for devices, implants and other healthcare products that must meet strict safety and performance standards. - The market’s projected growth signals stronger demand for materials that combine biocompatibility, flexibility and durability in medical manufacturing. - Rising use in implantables, wound care and prosthetics points to broader adoption across both treatment and recovery applications.

What happened: - The Business Research Company released its Medical Grade Silicone Market Report 2026, covering market size, trends and a global forecast through 2035. - The report estimates the market will rise from $2.55 billion in 2025 to $2.77 billion in 2026, a CAGR of 8.7%. - The report projects the market will reach $3.74 billion by 2030, with a CAGR of 7.8% over the forecast period. - North America was the largest regional market in 2025.

The details: - Medical grade silicone meets regulatory standards for use in healthcare settings. - The material is valued for flexibility, durability and resistance to heat and chemicals. - The report links recent growth to higher production of medical devices, expanding healthcare uses for silicone, stronger demand for biocompatible materials, growth in prosthetics and orthopedic treatments, and wider adoption of silicone-based medical products. - The report says future demand will be supported by advanced implantable devices, greater emphasis on patient safety and material compatibility, pharmaceutical applications, healthcare manufacturing investment, and the rising prevalence of chronic and orthopedic conditions. - The report identifies several expected trends: more silicone in implantables, higher demand for high-purity and biocompatible materials, wider use of liquid silicone rubber, expanded use in wound care and prosthetics, and greater preference for durable, flexible medical device components. - The report says medical grade silicone is used in the manufacture of medical devices, implants and related healthcare products. - The report includes coverage of Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The report also adds market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis, future trend analysis, and updated graphics and tables. - The release includes links for a free sample and the full report: Download a free sample and View the full report.

Between the lines: - The growth story is tied less to a single product cycle and more to structural demand from healthcare systems, device makers and material compliance requirements. - The emphasis on biocompatibility and high-purity inputs suggests buyers are prioritizing performance and regulatory fit over basic material availability. - The rise in registered medical products in the UK, from about 2.25 million in 2022 to about 3.25 million by April 2024, underscores how expanding device pipelines can feed demand for specialty inputs.

What's next: - The market is expected to keep expanding as chronic and orthopedic conditions increase demand for implants, prosthetics and related medical products. - Silicone producers and device makers are likely to lean more heavily on liquid silicone rubber, high-purity formulations and durable flexible components. - Regional competition will likely remain broad, with North America leading now and other major markets contributing to the forecast through 2030.